Guilin Sanjin Pharmaceutical Co Ltd (002275) — Free Cash Flow Generation Index
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-6.63 Million represents 0% of operating cash flow (CN¥117.62 Million). Read how much debt does Guilin Sanjin Pharmaceutical Co Ltd carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guilin Sanjin Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. Explore 002275 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Guilin Sanjin Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Guilin Sanjin Pharmaceutical Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | CN¥506.16 Million | CN¥588.33 Million | CN¥82.18 Million | ▼ -0.1% |
| 2023 | 0.86x | CN¥472.85 Million | CN¥549.25 Million | CN¥76.40 Million | ▼ -2.4% |
| 2022 | 0.88x | CN¥466.40 Million | CN¥528.67 Million | CN¥62.27 Million | ▲ +36.0% |
| 2021 | 0.65x | CN¥266.15 Million | CN¥410.24 Million | CN¥144.09 Million | ▼ -1.2% |
| 2020 | 0.66x | CN¥392.52 Million | CN¥597.99 Million | CN¥205.47 Million | ▲ +26.9% |
| 2019 | 0.52x | CN¥242.14 Million | CN¥468.29 Million | CN¥226.14 Million | ▼ -38.2% |
| 2018 | 0.84x | CN¥461.76 Million | CN¥551.73 Million | CN¥89.96 Million | ▼ -0.5% |
| 2017 | 0.84x | CN¥326.29 Million | CN¥387.82 Million | CN¥61.53 Million | ▼ -4.2% |
| 2016 | 0.88x | CN¥471.49 Million | CN¥536.85 Million | CN¥65.36 Million | ▲ +28.0% |
| 2015 | 0.69x | CN¥273.48 Million | CN¥398.50 Million | CN¥125.02 Million | ▲ +46.9% |
| 2014 | 0.47x | CN¥185.25 Million | CN¥396.53 Million | CN¥211.28 Million | ▲ +11069.8% |
| 2013 | 0.00x | CN¥1.31 Million | CN¥314.16 Million | CN¥312.85 Million | ▼ -98.7% |
| 2012 | 0.32x | CN¥96.96 Million | CN¥302.59 Million | CN¥205.63 Million | ▼ -49.0% |
| 2011 | 0.63x | CN¥214.30 Million | CN¥341.05 Million | CN¥126.75 Million | ▼ -4.1% |
| 2010 | 0.66x | CN¥187.05 Million | CN¥285.49 Million | CN¥98.44 Million | ▼ -22.9% |
| 2009 | 0.85x | CN¥308.61 Million | CN¥363.29 Million | CN¥54.68 Million | ▲ +6.5% |
| 2008 | 0.80x | CN¥152.33 Million | CN¥190.97 Million | CN¥38.64 Million | ▼ -10.7% |
| 2007 | 0.89x | CN¥146.80 Million | CN¥164.39 Million | CN¥17.59 Million | ▲ +3.1% |
| 2006 | 0.87x | CN¥188.51 Million | CN¥217.67 Million | CN¥29.16 Million | — |